您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > BETP
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
BETP
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
BETP图片
CAS NO:1371569-69-5
包装与价格:
包装价格(元)
2 mg电议
5 mg电议
10 mg电议
25 mg电议
50 mg电议
100 mg电议
1 mL*10 mM(in DMSO)电议

产品介绍
BETP 是胰高血糖素样肽 (GLP-1) 受体激动剂,能够抑制人和大鼠的GLP-1受体,其EC50值分别为 0.66 μM 和 0.755 μM。

产品描述

BETP is an agonist of GLP-1 receptor (EC50s: 0.66 and 0.755 μM for human and rat GLP-1 receptor).

体外活性

BETP (Compound B) is inactive in cells expressing the GLP-2, GIP, PTH, or glucagon receptors. BETP (1-10 μM) enhances insulin secretion in normal and diabetic human islets. In addition, BETP in combination with GLP-1 shows additive effects on increasing GLP-1 receptor signaling [1]. BETP increases the potency of oxyntomodulin by 10-fold (EC50: 80 pM). GLP-1 does not change the potencies and efficacies of both oxyntomodulin and glucagon at the glucagon receptor. BETP (0-30 μM) increases the binding affinity of oxyntomodulin for the GLP-1 receptor [2].

体内活性

BETP (10 mg/kg, jugular vein cannula) exhibits insulin secretagogue activity in the intravenous glucose tolerance test (IVGTT) model. BETP (10 mg/kg, i.v.)-treated rats need 20% higher glucose infusion rates and demonstrate higher plasma insulin levels in the SD rat hyperglycemic clamp model [1]. BETP (5 mg/kg) enhances oxyntomodulin-stimulated insulin secretion [2].

动物实验

IVGTT studies are performed. Male SD rats are group-housed three per cage in polycarbonate cages with filter tops. Rats are maintained on a 12:12 h light-dark cycle (lights on at 6:00 a.m.) at 21°C and receive diet and deionized water ad libitum. Rats were fasted overnight and anesthetized with 60 mg/kg pentobarbital for the duration of the experiment. For glucose and compounds (BETP, etc.) administration, a catheter with a diameter of 0.84 mm is inserted into the jugular vein. For rapid blood collection, a larger catheter with 1.02-mm diameter is inserted into the carotid artery. Blood is collected for glucose and insulin levels at times 0, 2, 4, 6, 10, and 20 min after intravenous administration of the BETP which is immediately followed by an intravenous glucose bolus of 0.5 g/kg. Plasma levels of glucose and insulin are determined [1].

Cas No.

1371569-69-5

分子式

C20H17F3N2O2S

分子量

406.42

储存和溶解度

H2O:Insoluble
DMSO:25 mg/mL (61.51 mM),Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years